Compass Therapeutics
Clinical trials sponsored by Compass Therapeutics, explained in plain language.
-
New hope for advanced colon cancer: experimental drug CTX-009 tested
Disease control CompletedThis study tested an experimental drug called CTX-009 in 49 adults with metastatic colorectal cancer that had worsened after two or three prior treatments. The goal was to see if the drug could shrink tumors or stop cancer growth. Participants received CTX-009 and were monitored …
Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 17, 2026 05:27 UTC
-
New hope for patients whose cancers resist immunotherapy
Disease control CompletedThis early-stage study tested an experimental drug called CTX-471, given alone or with another immunotherapy (pembrolizumab), in 100 adults with advanced solid tumors that had stopped responding to standard PD-1/PD-L1 inhibitors. The main goal was to check safety and find the rig…
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC